Sollima, A.; Rossini, F.; Lanza, P.; Pallotto, C.; Meschiari, M.; Gentile, I.; Stellini, R.; Lenzi, A.; Mulé, A.; Castagna, F.;
et al. Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art. Antibiotics 2024, 13, 453.
https://doi.org/10.3390/antibiotics13050453
AMA Style
Sollima A, Rossini F, Lanza P, Pallotto C, Meschiari M, Gentile I, Stellini R, Lenzi A, Mulé A, Castagna F,
et al. Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art. Antibiotics. 2024; 13(5):453.
https://doi.org/10.3390/antibiotics13050453
Chicago/Turabian Style
Sollima, Alessio, Francesco Rossini, Paola Lanza, Carlo Pallotto, Marianna Meschiari, Ivan Gentile, Roberto Stellini, Angelica Lenzi, Alice Mulé, Francesca Castagna,
and et al. 2024. "Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art" Antibiotics 13, no. 5: 453.
https://doi.org/10.3390/antibiotics13050453
APA Style
Sollima, A., Rossini, F., Lanza, P., Pallotto, C., Meschiari, M., Gentile, I., Stellini, R., Lenzi, A., Mulé, A., Castagna, F., Lorenzotti, S., Amadasi, S., Van Hauwermeiren, E., Saccani, B., Fumarola, B., Signorini, L., Castelli, F., & Matteelli, A.
(2024). Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art. Antibiotics, 13(5), 453.
https://doi.org/10.3390/antibiotics13050453
